NPH Insulin

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

5-Year Study Published In Diabetologia Demonstrated Long-Term Safety Of Lantus(R) Compared To NPH

Published July 7, 2009, 5:14 am, Medical News Today

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the results of the long-term, 5-year study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia (DOI 10.1007/s00125-009-1415-7) showed similar effects on retinopathy and overall safety in the two treatment groups.

Discover News | Full Story


Sanofi-aventis' Lantus 5-yr study shows safety & efficiency

Published July 6, 2009, 10:48 pm, PharmaBiz

Sanofi-aventis announced that the results of the long-term, five-year study of Lantus (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type-2 diabetes, published on-line in Diabetologia (DOI 10.1007/s00125-009-1415-7) showed similar effects on retinopathy and overall safety in the two treatment groups.

Discover News | Full Story


5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

Published July 6, 2009, 7:57 am, redOrbit

/PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the results of the long-term, 5-year study of Lantus(R) (insulin glargine [rDNA] injection) versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia

Discover News | Full Story


5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH

Published July 6, 2009, 5:00 am, PR Newswire via Yahoo! Finance

Sanofi-aventis announced today that the results of the long-term, 5-year study of LantusĀ® versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia showed similar effects on retinopathy and overall safety in the two treatment groups.

Discover News | Full Story


(AFX UK Focus) 2009-07-06 07:44 French and Benelux stocks - Factors to watch on July 6

Published July 6, 2009, 12:08 am, Interactive Investor

PARIS, July 6 (Reuters) - Below is company-related news and leading stories from French and Benelux newspapers which could have an impact on the region's markets or individual stocks.

Discover News | Full Story


(AFX UK Focus) 2009-07-06 07:15 Glance-European Factors-Shares set to track losses in Asia

Published July 5, 2009, 11:37 pm, Interactive Investor

PARIS, July 6 (Reuters) - European equities were set to fall on Monday, tracking losses in Asia as investors remain cautious on the prospect of an early global economic recovery and ahead of the start of earnings season for the second quarter.

Discover News | Full Story


(AFX UK Focus) 2009-07-06 06:19 BRIEF-Sanofi-Aventis says 5-year study shows long-term safety of Lantus

Published July 5, 2009, 10:22 pm, Interactive Investor

PARIS, July 6 (Reuters) - Sanofi-Aventis SA:

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a